|
市場調査レポート
商品コード
1550535
がん治療・バイオ治療の世界市場：用途別、治療タイプ別、エンドユーザー別、地域別Global Cancer Therapeutics And Biotherapeutics Market, By Application, By Therapy Type, By Application, By End User, By Geography |
||||||
カスタマイズ可能
|
|||||||
| がん治療・バイオ治療の世界市場：用途別、治療タイプ別、エンドユーザー別、地域別 |
|
出版日: 2024年07月30日
発行: Coherent Market Insights
ページ情報: 英文 175 Pages
納期: 2～3営業日
|
- 全表示
- 概要
- 目次
世界のがん治療・バイオ治療の市場規模は、2024年の1,941億1,000万米ドルから、2031年までに3,441億米ドルに達し、2024年～2031年の間にCAGR8.5%で成長すると予測されています。
| レポート範囲 | レポート詳細 | ||
|---|---|---|---|
| 基準年 | 2023年 | 2024年の市場規模 | 1,941億1,000万米ドル |
| 実績データ | 2019年～2023年 | 予測期間 | 2024年～2031年 |
| 予測期間2024年～2031年 CAGR： | 8.50% | 2031年の価値予測 | 3,441億米ドル |
がん治療・バイオ治療は、世界的に大きく成長する市場です。化学療法などの従来の治療法には限界がある一方で、新しい生物学的療法や標的療法はがん治療に革命をもたらしています。生物学的療法は、ヒトの免疫系の力を利用したり、モノクローナル抗体やその他の薬剤を用いてがん細胞の増殖を阻害したりします。標的療法は、急速に分裂する正常細胞やがん細胞すべてに作用する化学療法とは異なり、がん細胞に見られる特定の分子標的に焦点を当てるものです。がん生物学の理解と技術革新の進歩に伴い、様々な生物学的製剤や標的療法が開発され、商品化されています。これらの新しい治療アプローチは、多くのがん患者の生存期間と生活の質を向上させています。
市場力学：
世界のがん治療・バイオ治療市場の成長は、世界のがん罹患率の上昇、個別化医療に対する需要の高まり、がん治療薬開発のための研究資金の増加、新規の標的治療薬および生物学的治療薬の発売によってもたらされます。しかし、生物学的製剤や標的治療薬の開発コストが高く、それに伴う技術的課題が市場の成長を抑制しています。より新しいメカニズムや併用療法に関する研究開発が進められていることが、市場拡大の機会となっています。
本調査の主な特徴
本レポートでは、世界のがん治療・バイオ治療市場を詳細に分析し、2023年を基準年とした予測期間（2024年～2031年）の市場規模（10億米ドル）と年間平均成長率（CAGR%）を掲載しています。
また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案マトリクスについて解説しています。
また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
世界のがん治療・バイオ治療市場における主要企業プロファイルを、企業ハイライト、製品ポートフォリオ、主要ハイライト、財務実績、戦略などのパラメータに基づいて掲載しています。
主要企業には、ロシュ、ノバルティス、ファイザー、アストラゼネカ、グラクソ・スミスクライン、アッヴィなどが含まれます。
本レポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品上市、タイプアップ、市場拡大、マーケティング戦術に関して、情報に基づいた意思決定を行うことができます。
この調査レポートは、投資家、サプライヤー、製品メーカー、販売業者、新規参入者、財務アナリストなど、この業界のさまざまな利害関係者を対象としています。
利害関係者は、世界のがん治療・バイオ治療市場の分析に使用される様々な戦略マトリックスを通じて、意思決定を容易にすることができます。
目次
第1章 調査の目的と前提条件
- 調査目的
- 前提条件
- 略語
第2章 市場の展望
- レポートの説明
- 市場の定義と範囲
- エグゼクティブサマリー
- Coherent Opportunity Map（COM）
第3章 市場力学、規制、動向分析
- 市場力学
- 促進要因
- 抑制要因
- 機会
- 影響分析
- 市場動向
- 主な発展
- 規制シナリオ
- 買収と提携のシナリオ
- 資金調達と投資
- PEST分析
- ポーターの分析
第4章 世界のがん治療・バイオ治療市場- 新型コロナウイルス（COVID-19）パンデミックの影響
- 全体的な影響
- 政府の取り組み
- COVID-19による市場への影響
第5章 世界のがん治療・バイオ治療市場：用途別（2019年～2031年）
- 血液がん
- 肺がん
- 大腸がん
- 前立腺がん
- 子宮頸がん
- 頭頸部がん
- 膠芽腫
- 悪性髄膜腫
- 中皮腫
- 悪性黒色腫
- その他
第6章 世界のがん治療・バイオ治療市場：治療タイプ別（2019年～2031年）
- 化学療法
- 放射線治療
- ホルモン療法
- バイオセラピー
- その他
第7章 世界のがん治療・バイオ治療市場：エンドユーザー別（2019年～2031年）
- 病院・クリニック
- がんケアセンター
- 研究機関
- その他
第8章 世界のがん治療・バイオ治療市場：地域別（2019年～2031年）
- ラテンアメリカ
- 欧州
- アジア太平洋
- 中東
第9章 競合情勢
- 企業プロファイル
- Amgen Inc.
- Bristol-Myers Squibb
- Celgene Corporation
- ELI Lilly and Company
- Hoffmann-La Roche AG
- EnGeneIC Ltd
- Merck &Co Inc.
- Novartis
- Pfizer Inc.
- Johnson &Johnson
- AstraZeneca
- Bristol-Myers Squibb
- Biogen IDEC
- Sanofi
- Novartis AG
- Roche
- Schering-Plough
- Gilead Sciences
- Takeda Pharmaceutical Company
第10章 アナリストの推奨事項
- Wheel of Fortune
- アナリストの見解
- Coherent Opportunity Map（COM）
第11章 参考文献と調査手法
- 参考文献
- 調査手法
The Global Cancer Therapeutics and Biotherapeutics Market is estimated to be valued at USD 194.11 Bn in 2024 and is expected to reach USD 344.10 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.5% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 194.11 Bn |
| Historical Data for: | 2019 To 2023 | Forecast Period: | 2024 To 2031 |
| Forecast Period 2024 to 2031 CAGR: | 8.50% | 2031 Value Projection: | US$ 344.10 Bn |
Cancer therapeutics and biotherapeutics is a large and growing market globally. While conventional treatment options such as chemotherapy have limitations, newer biological and targeted therapies are revolutionizing cancer treatment. Biological therapies harness the power of the human immune system or block cancer cell growth using monoclonal antibodies or other agents. Targeted cancer therapies focus on specific molecular targets found in cancer cells unlike chemotherapy which affects all rapidly dividing normal and cancerous cells. With advances in understanding cancer biology and technological innovations, a wide range of biologics and targeted therapies are being developed and commercialized. These newer therapeutic approaches have improved survival and quality of life for many cancer patients.
Market Dynamics:
The global cancer therapeutics and biotherapeutics market growth is driven by the rising global cancer burden, growing demand for personalized medicine, increasing research funding for cancer drug development, and launch of novel targeted and biological therapies. However, high developmental costs of biologics and targeted drugs along with associated technical challenges are restraining the market growth. Ongoing R&D for newer mechanisms and combination therapies provide opportunities for market expansion.
Key Features of the Study:
This report provides in-depth analysis of the global cancer therapeutics and biotherapeutics market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global cancer therapeutics and biotherapeutics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Roche, Novartis, Pfizer, AstraZeneca, GlaxoSmithKline and AbbVie.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global cancer therapeutics and biotherapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cancer therapeutics and biotherapeutics market
Detailed Segmentation-
- By Application
- Blood Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Breast Cancer
- Cervical Cancer
- Head and Neck Cancer
- Giloblastoma
- Malignant Meningioma
- Mesothelioma
- Melanoma
- Others
- By Therapy Type
- Chemotherapy
- Targeted Therapy
- Immunotherapy
- Radiation Therapy
- Hormone Therapy
- Biotherapy
- Others
- By End User
- Hospitals & Clinics
- Cancer Care Centers
- Research Institutes
- Others
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Amgen Inc.
- Bristol-Myers Squibb
- Celgene Corporation
- ELI Lilly and Company
- Hoffmann-La Roche AG
- EnGeneIC Ltd
- Merck & Co Inc.
- Novartis
- Pfizer Inc.
- Johnson & Johnson
- AstraZeneca
- Bristol-Myers Squibb
- Biogen IDEC
- Sanofi
- Novartis AG
- Roche
- Schering-Plough
- Gilead Sciences
- Takeda Pharmaceutical Company
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Application
- Market Snapshot, By Therapy Type
- Market Snapshot, By End Users
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Cancer Therapeutics and Biotherapeutics Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Cancer Therapeutics and Biotherapeutics Market, By Application, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Blood Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Lung Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Colorectal Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Prostate Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Cervical Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Head and Neck Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Giloblastoma
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Malignant Meningioma
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Mesothelioma
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Melanoma
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Cancer Therapeutics and Biotherapeutics Market, By Therapy Type, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Chemotherapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Radiation Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Hormone Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Biotherapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Cancer Therapeutics and Biotherapeutics Market, By End-User, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Hospitals & Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Cancer Care Centers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Research Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
8. Global Cancer Therapeutics and Biotherapeutics Market, By Region, 2019 - 2031, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Clinical Applications, 2019
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Company Profiles
- Amgen Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bristol-Myers Squibb
- Celgene Corporation
- ELI Lilly and Company
- Hoffmann-La Roche AG
- EnGeneIC Ltd
- Merck & Co Inc.
- Novartis
- Pfizer Inc.
- Johnson & Johnson
- AstraZeneca
- Bristol-Myers Squibb
- Biogen IDEC
- Sanofi
- Novartis AG
- Roche
- Schering-Plough
- Gilead Sciences
- Takeda Pharmaceutical Company
- Amgen Inc.
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
